A variety of medications can disrupt the lining of the gastrointestinal tract or cause GI complaints that can mimic certain conditions, such as inflammatory bowel disease and irritable bowel syndrome. Medications may produce these symptoms by altering GI physiology, increasing tissue toxicity, or interacting with the intestinal microbiota. From a clinical perspective, it may be helpful to distinguish between medication-induced GI symptoms and IBD or IBS in order to identify optimal treatment strategies.
For example, medications that may have an impact on the GI microbiome include antibiotics, proton pump inhibitors, and non-steroidal anti-inflammatory drugs. The GI microbiome consists of a large number of microorganisms associated with complex metabolic processes. A systematic review of the effect of antibiotics on the GI microbiome found that antibiotic use has been associated with dysbiosis of the microbiota. Antibiotics can negatively impact the beneficial diversity of the GI microbiome in both adults and children. The short-term GI effects of antibiotic use may include C. difficile infection, diarrhea, gastritis, bloating, intestinal pain, and compromised intestinal barrier function. Prolonged use of antibiotics has been associated with the development of antimicrobial resistance and IBS.
PPIs can be prescribed or taken over the counter and are used for the management of occasional or chronic heartburn. By suppressing gastric acid secretion, they may also impact the GI microbiota by reducing its diversity and leading to increased incidence of GI infections, such as those triggered by C. difficile, Salmonella, and Campylobacter. Prolonged use of PPIs has been associated with impaired nutrient absorption and an increased likelihood for H. pylori to colonize the stomach, which may lead to hypergastrinemia. NSAIDs comprise another class of medications that may impact the GI microbiome composition and the expansion of opportunistic bacteria through unintended toxicity. Gastrointestinal complaints associated with the use of NSAIDs include heartburn, reflux, dyspepsia, bloating, nausea, abdominal pain, diarrhea, constipation, ulcers, and gastrointestinal bleeding.
Weight-loss medications, such as glucagon-like peptide-1 receptor agonists, work by mimicking the GLP-1 hormone, which is released by the gastrointestinal mucosa after consuming a meal and signals to the pancreas to produce more insulin, while suppressing glucagon secretion. A meta-analysis examining the effects of GLP-1 RAs reported associated GI disturbances, such as nausea, diarrhea, and vomiting. A study based on the FDA adverse event reporting system found that GLP-1 RAs were associated with increased risk of gastrointestinal system disorders including gastroesophageal reflux disease, nausea, diarrhea, vomiting, constipation, upper abdominal pain, gastritis, bezoar, breath odor, pancreatitis, and intra-abdominal hematoma.
Can nutrients support those with medication-induced GI complaints?
Certain amino acids, botanicals, functional foods, and minerals may offer support for GI health and function and help mitigate some of the GI effects associated with medications.
Learn more about nutrients supporting GI health:
Herbs and Botanicals for Optimal Gut Health
Deglycyrrhizinated Licorice in Promoting Gastric Mucosal Health
Zinc Carnosine for Gastric Mucosal Health
By Antonia Toupet, PhD